The Iliac/SFA/Popliteal Center

Filter Your Results




Use Caution in Comparing SFA Trial Data

William A. Gray, MD; and Mario Landini

September 2018—Not all superficial femoral artery device trials are created equal—in fact, none are.

Roundtable Discussion: Surveying the Landscape: SFA Drug Delivery Trial Designs and Data

Moderator: William A. Gray, MD
Panel: Gary M. Ansel, MD; Koen Deloose, MD; Michael R. Jaff, DO; and Peter A. Schneider, MD

September 2018—Experts discuss key elements of SFA trials, whether a global algorithmic approach to treating SFA disease is possible, and the limitations of cross-trial platform comparisons.

SPEED: A New Initiative in Real-World PAD Evidence Evaluation

Misti Malone, PhD

September 2018—An overview of the FDA’s new multistakeholder project to support real-world evidence evaluation for devices aimed at treating peripheral artery disease.

Separating Regulatory and Clinical Standards

Gary M. Ansel, MD; and Raghu Kolluri, MD, RVT, RPVI

September 2018—Understanding the FDA device approval process and the difference between data from premarket and postapproval trials to make informed clinical decisions.

Challenges Facing Current and Next-Generation SFA Technologies

Krishna Rocha-Singh, MD

September 2018—A discussion of anatomic barriers to treatment, evolving trial designs, and the impact of reimbursement.

Roundtable Discussion: SFA Vessel Prep in the Real World

Moderator: Marianne Brodmann, MD
Panel: Ehrin J. Armstrong, MD; Lawrence A. Garcia, MD; Gunnar Tepe, MD; Jos C. van den Berg, MD, PhD; and Thomas Zeller, MD

September 2018—A discussion on the current role of vessel preparation, when to use it and when not to use it, device selection, and data related to cost-effectiveness and algorithm creation.

Options for In-Stent Restenosis in 2018

Brian G. DeRubertis, MD, FACS

September 2018—Capabilities and limitations of current technologies and available data.

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

September 2018—Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.